MarDee Haring-Layton - 30 Jan 2026 Form 4 Insider Report for Dare Bioscience, Inc. (DARE)

Role: Chief Accounting Officer
Signature: /s/ MarDee Haring-Layton
Issuer symbol: DARE
Transactions as of: 30 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 02 Feb 2026, 16:05:49 UTC
Previous filing: 04 Sep 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Haring-Layton MarDee	Chief Accounting Officer	C/O DARE BIOSCIENCE, INC., 3655 NOBEL DRIVE, SUITE 260, SAN DIEGO	/s/ MarDee Haring-Layton	02 Feb 2026	0001535596

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DARE	Employee Stock Option (right to buy)	Award	$0	+49,000		$0.000000	49,000	30 Jan 2026	Common stock	49,000	$1.81	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer.